The early increased levels of Hsp90 in some SLE patients is primarily dependent upon the enhanced transcription of the HSP90β gene, suggesting the activation of a specific gene program underlying the pathogenic mechanism of the disease [40,41,42]. This evidence concerns the gene HSP90AB1 and systemic lupus erythematosus.